The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2022

Filed:

Aug. 31, 2017
Applicant:

Kyoto University, Kyoto, JP;

Inventors:

Masatoshi Hagiwara, Kyoto, JP;

Akiko Kobayashi, Kyoto, JP;

Takamitsu Hosoya, Tokyo, JP;

Suguru Yoshida, Tokyo, JP;

Yuto Sumida, Tokyo, JP;

Assignee:

Kyoto University, Kyoto, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/443 (2006.01); A61P 43/00 (2006.01); A61P 25/24 (2006.01); A61K 31/4709 (2006.01); A61P 25/16 (2006.01); A61K 45/00 (2006.01); A61P 25/14 (2006.01); A61P 25/02 (2006.01); A61K 31/4439 (2006.01); A61K 31/4725 (2006.01); A61P 25/28 (2006.01); A61P 25/00 (2006.01); A61K 31/416 (2006.01); C12N 5/0793 (2010.01);
U.S. Cl.
CPC ...
A61K 31/47 (2013.01); A61K 31/416 (2013.01); A61K 31/443 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 45/00 (2013.01); A61P 25/00 (2018.01); A61P 25/02 (2018.01); A61P 25/14 (2018.01); A61P 25/16 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 43/00 (2018.01); C12N 5/0619 (2013.01);
Abstract

Provided is a composition for activating neurogenesis, use of the composition, and a method for preventing, improving, inhibiting the development of, and/or treating a disease or the like of the central nervous system and or the peripheral nervous system using the composition. A composition for activating neurogenesis contains, as an active ingredient, a compound having an ability to inhibit phosphorylation activity of a protein kinase or a prodrug thereof, or a pharmaceutically acceptable salt thereof, and a composition for preventing, improving, inhibiting the development of, and/or treating a disease of the central nervous system and/or the peripheral nervous system, or for improving, inhibiting the development of, and/or treating a functional disorder of the central nervous system and/or the peripheral nervous system, the composition containing, as an active ingredient, a compound having an ability to inhibit phosphorylation activity of a protein kinase or a prodrug thereof, or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…